SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-23-000093
Filing Date
2023-01-18
Accepted
2023-01-18 13:30:47
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING ATARA BIOTHERAPEUTICS, INC. ATARA_BIOTHERAPEUTICS_INC..htm SC 13G/A 88017
  Complete submission text file 0000019617-23-000093.txt   89884
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

IRS No.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88393
SIC: 2836 Biological Products, (No Diagnostic Substances)